TSB Therapeutics, the holding company of Brii Bio, and Sinopharm have entered into a strategic collaboration to commercialize Brii Bio's long-acting neutralizing monoclonal antibody...
Innovent Biologics, Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and...
Henlius Biotech, Inc. announced that its first self-developed innovative PD-1 inhibitor HANSIZHUANG (generic name: serplulimab injection) has been approved by the National Medical Products...
Bavarian Nordic announced, that it has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-based specialty pharmaceutical company, on the...
Chinese companies to step up pharmaceutical cooperation with Pakistan, China Economic Net reported.
Mr. Xin Chunlin from CanSino on the recently held CPEC B2B Conference...
The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today...